The company behind Opill didn't release specific data but said Monday in a statement that sales "have grown on a weekly basis ...

There are plenty of reasons to consider coming off the pill, from wanting to conceive to trying to get back in touch with your regular rhythms. But beware the people online who demonise hormonal ...

While, on average, it takes eight years to be diagnosed with endometriosis, there are, thankfully, new breakthroughs in ...

The first-of-its-kind endometriosis pill provides hope for 1.5 million people in the UK affected by the condition ...

Endometriosis occurs when cells similar to those in the lining of the womb grow in other parts of the body, such as the ...

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo) is the first long-term daily ...

The UK's NHS has approved a first daily pill, relugolix combination therapy, to treat endometriosis symptoms. The new ...

A transformational new pill for treating endometriosis has been approved for use on the NHS across England. The new tablet, ...

The first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England and Wales - but only ...